Literature DB >> 7020043

The epidemiology of pneumococcal disease in infants and children.

J O Klein.   

Abstract

Streptococcus pneumoniae is the most frequent bacterial cause of pneumonia, otitis media, and bacteremia and is the third most common cause of meningitis in infants and children. Infants have the highest rates of pneumococcal disease. Recent studies showed that the peak incidence of meningitis occurs among infants three to five months of age, that of otitis media occurs among infants six to 12 months of age, and that of hospitalization for pneumonia occurs among infants 13 to 18 months of age. A predominance of males was noted in most studies of pneumococcal disease. Blacks have higher rates of bacteremia and meningitis than do whites; this difference is explained only in part by the greater susceptibility to infection of children with sickle cell disease. However, the incidence of otitis media is lower in blacks than in whites. The predominant pneumococcal serotypes change with age, with time, and with geographic location. Certain serotypes are responsible for most cases of bacteremia or meningitis. Types present in the pneumococcal vaccine currently available represent 85% to 97% of the strains that have caused disease in the United States in recent years.

Entities:  

Mesh:

Year:  1981        PMID: 7020043     DOI: 10.1093/clinids/3.2.246

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  53 in total

1.  Predicting cost-benefits before programs are started: looking at conjugate vaccine for invasive pneumococcal infections.

Authors:  W J Hueston; A G Mainous; N Brauer
Journal:  J Community Health       Date:  2000-02

2.  Influence of patient age on Streptococcus pneumoniae serotypes causing invasive disease.

Authors:  J Inostroza; A M Vinet; G Retamal; P Lorca; G Ossa; R R Facklam; R U Sorensen
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

3.  Trends in resistance to penicillin and erythromycin of invasive pneumococci in Portugal.

Authors:  R Dias; M Caniça
Journal:  Epidemiol Infect       Date:  2007-08-16       Impact factor: 2.451

4.  Serotypes of Streptococcus pneumoniae causing invasive childhood infections in Bangladesh, 1992 to 1995.

Authors:  S K Saha; N Rikitomi; D Biswas; K Watanabe; M Ruhulamin; K Ahmed; M Hanif; K Matsumoto; R B Sack; T Nagatake
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

5.  Health outcomes and services in children with sickle cell trait, sickle cell anemia, and normal hemoglobin.

Authors:  Sarah L Reeves; Hannah K Jary; Jennifer P Gondhi; Mary Kleyn; Kevin J Dombkowski
Journal:  Blood Adv       Date:  2019-05-28

6.  Immunization of female mice with glycoconjugates protects their offspring against encapsulated bacteria.

Authors:  Margret Y Richter; Håvard Jakobsen; Alda Birgisdottir; Jean-François Haeuw; Ultan F Power; Giuseppe Del Giudice; Antonella Bartoloni; Ingileif Jonsdottir
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  Role of spleen in immune response to polyvalent pneumococcal vaccine.

Authors:  F Di Padova; M Dürig; J Wadström; F Harder
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-17

8.  Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A.

Authors:  S Langermann; S R Palaszynski; J E Burlein; S Koenig; M S Hanson; D E Briles; C K Stover
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

Review 9.  Treatment of bacterial meningitis.

Authors:  U B Schaad
Journal:  Eur J Clin Microbiol       Date:  1986-10       Impact factor: 3.267

10.  Immunogenicity of a live recombinant Salmonella enterica serovar typhimurium vaccine expressing pspA in neonates and infant mice born from naive and immunized mothers.

Authors:  Huoying Shi; Shifeng Wang; Kenneth L Roland; Bronwyn M Gunn; Roy Curtiss
Journal:  Clin Vaccine Immunol       Date:  2010-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.